Journal
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
Volume 13, Issue -, Pages 3009-3034Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/DMSO.S253920
Keywords
gestational diabetes mellitus; miRNA-21; insulin resistance; PPAR-alpha
Categories
Funding
- National Key Research and Development Program of China [2016YFC1000307]
- National Natural Science Foundation of China [81771590]
- CAMS Innovation Fund for Medical Sciences (CIFMS) [2018-I2M-1-004]
- National Research Institute for Family Planning [2018GLZ04]
Ask authors/readers for more resources
Purpose: This study aimed to investigate the role of miR-21 expression in the reduction of placental function in GDM patients. Materials and Methods: qRT-PCR was used to detect the differential expression of miR-21 in the serum of gestational diabetes mellitus (GDM) and normal pregnant women, and to verify the functional target gene PPAR-alpha of miR-21 by double fluorescence experiments. Cellular experiments were performed to verify the effect of PPAR-alpha on cell function. Results: miR-21 is down-regulated in the serum and placenta of GDM patients compared to normal pregnant women. In the case of insulin resistance, miR-21-5p knockdown promoted glucose uptake, but no significant effect was found under physiological condition. Functional studies have shown that reduced PPAR-a expression can restore miR-21 knockdown-mediated cell growth and metastasis inhibition. Additionally, decreased expression of miR21 but increased expression of -PPAR-alpha was observed in patients with GDM and GDM rats. Conclusion: The expression of the placental miR-21-5p, which inhibits cell growth and infiltration by up-regulating PPAR-alpha, is downregulated in pregnant GDM patients, which in turn may affect the placental function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available